Abstract
The mounting evidences have shown that signal transducer and activator of transcription 3 (Stat3) is a critical target for cancer therapy. Recently, we developed a G-quartet oligonucleotide T40214 as a novel and potent Stat3 inhibitor. T40214 specifically inhibited DNA-binding activity of Stat3 and significantly suppressed the growth of many tumor xenografts in nude mice. To determine the mechanism of GQ-ODNs selectively targeting Stat3, we established a 3D model of complex T40214/p-Stat3 dimer based on experimental evidences. The binding site of T40214 within Stat3 dimer was determined by statistical docking analysis. The results indicated that T40214 strongly interacted within the region from residue E638 through E652 of Stat3 dimer. The binding model refined by Hex docking disclosed that T40214 binds to SH2 domain of Stat3 and forms H-bonds with residues Q643, Q644, N646, and N647, which are critical for the binding interaction. The 3D models also suggested that T40214 inhibits Stat3 activity through disrupting the binding interaction between Stat3 dimer and DNA duplex for transcription. Our computational studies provided a platform for future structure-based drug design of novel Stat3 inhibitors.
Similar content being viewed by others
References
Darnell JE (1997) Science 277:1630
Bromberg J, Darnell JE (2000) Oncogene 19:2468
Darnell JE (2002) Nat Rev Cancer 2:740
Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L (1998) Biochem J 334(Pt 2):297
Hirano T, Ishihara K, Hibi M (2000) Oncogene 19:2548
Takeda K, Akira S (2000) Cytokine Growth Factor Rev 11:199
Lutticken C, Wegenka UM, Yuan J, Buschmann J, Schindler C, Ziemiecki A, Harpur AG, Wilks AF, Yasukawa K, Taga T et al (1994) Science 263:89
Raz R, Durbin JE, Levy DE (1994) J Biol Chem 269:24391
Wegenka UM, Lutticken C, Buschmann J, Yuan J, Lottspeich F, Muller-Esterl W, Schindler C, Roeb E, Heinrich PC, Horn F (1994) Mol Cell Biol 14:3186
Zhong Z, Wen Z, Darnell JE Jr (1994) Science 264:95
Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS, Jove R (1999) Immunity 10:105
Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy DJ (1998) J Clin Invest 102:1385
Bowman T, Garcia R, Turkson J, Jove R (2000) Oncogene 19:2474
Buettner R, Mora LB, Jove R (2002) Clin Cancer Res 8:945
Silvennoinen O, Schindler C, Schlessinger J, Levy DE (1993) Science 261:1736
Darnell JE Jr, Kerr IM, Stark GR (1994) Science 264:1415
Levy DE, Darnell JE Jr (2002) Nat Rev Mol Cell Biol 3:651
Becker S, Groner B, Muller CW (1998) Nature 394:145
Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, Kuriyan J (1998) Cell 93:827
Xu X, Sun YL, Hoey T (1996) Science 273:794
Horvath CM, Wen Z, Darnell JE Jr (1995) Genes Dev 9:984
Shuai K, Horvath CM, Huang LH, Qureshi SA, Cowburn D, Darnell JE Jr (1994) Cell 76:821
Jing N, Tweardy DJ (2005) Anticancer Drugs 16:601
Jing N, Li Y, Xu X, Sha W, Li P, Feng L, Tweardy DJ (2003) DNA Cell Biol 22:685
Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N (2007) Int J Oncol 31:129
Jing N, Zhu Q, Yuan P, Li Y, Mao L, Tweardy DJ (2006) Mol Cancer Ther 5:279
Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ (2004) Cancer Res 64:6603
Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y, Kim JD (2000) Proc Natl Acad Sci USA 97:4227
Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BR, Stark GR (2000) Embo J 19:263
Yu H, Jove R (2004) Nat Rev Cancer 4:97
Jing N, Hogan ME (1998) J Biol Chem 273:34992
Pearlmann DA, Case DA, Caldwell JW, Ross WS, Cheatham TE, III DeBolt S, Ferguson D, Seibel G, Kollman P (1995) Comp Phys Commun 91:1
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) Nucleic Acids Res 28:235
Berman HM, Olson WK, Beveridge DL, Westbrook J, Gelbin A, Demeny T, Hsieh SH, Srinivasan AR, Schneider B (1992) Biophys J 63:751
Ritchie DW, Kemp GJ (2000) Proteins 39:178
Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O’Donovan C, Phan I, Pilbout S, Schneider M (2003) Nucleic Acids Res 31:365
Thompson JD, Higgins DG, Gibson TJ (1994) Nucleic Acids Res 22:4673
Neculai D, Neculai AM, Verrier S, Straub K, Klumpp K, Pfitzner E, Becker S (2005) J Biol Chem 280:40782
Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, Wang W, McMurray JS, Demeler B, Darnell JE Jr, Chen X (2005) Mol Cell 17:761
Soler-Lopez M, Petosa C, Fukuzawa M, Ravelli R, Williams JG, Muller CW (2004) Mol Cell 13:791
Acknowledgments
The authors wish to thank Yidong Li, who contributed to this study by providing the EMSA results. This project was supported by the following grants: CA104035 (NIH) and competitive award from Prostate Cancer Foundation. In addition, Dr. Zhu received support through NIH training grant T32 DK60445.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhu, Q., Jing, N. Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3. J Comput Aided Mol Des 21, 641–648 (2007). https://doi.org/10.1007/s10822-007-9147-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-007-9147-6